Summary
Priapism is characterised by a persistent erection that cannot be relieved by sexual intercourse or masturbation. Although priapism subsides spontaneously in a few days, impotence frequently follows. Both vascular and neural mechanisms are implicated in the pathophysiology of priapism, but it is not clear which initiates the process.
Idiopathic cases of priapism are the most frequent (near 50%); other medical conditions that can result in priapism are haematological diseases (mainly sickle cell anaemia and leukaemia), traumatism, and neoplastic processes. Drug-induced priapism comprises about 30% of cases. The drugs most frequently implicated are psychotropic drugs (phenothiazines and trazodone), antihypertensives (mainly prazosin) and heparin. Recently, the intracav-ernosal injection of vasoactive drugs (papaverine and phentolamine) has been described in patients treated for impotence. With the exception of heparin, an α-adrenergic blocking mechanism has been suggested in the priapism-inducing action of these drugs.
A significant number of anecdotal case reports link priapism and drugs, and it is possible that certain cases of idiopathic priapism could be reclassified if accurate pharmacological anamnesis were to be performed.
Priapism must be considered a urological emergency. Surgical procedures are the most preferred treatment for this condition but, in selected cases, drug treatment seems to be an alternative approach.
Similar content being viewed by others
References
Abber JC, Lue TF, Luo JA, Juenemann KP, Tanagho EA. Priapism induced by chlorpromazine and trazodone: mechanism of action. Journal of Urology 137: 1039–1042, 1987
Adams JW, Soucheray JA. Prazosin induced priapism in a diabetic. Journal of Urology 132: 1208, 1984
Adjiman S, Fava P, Bitker MO, et al. Heparin-induced priapism: a more serious prognosis. Annales d’Urologie 22: 125–128, 1988
Amlie RN, Burgeois B, Huxtable RF. Priapism in preterm infant. Urology 9: 558, 1977
Anderson PO, Bloom SR, Mellander S. Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide. Journal of Physiology 350: 209–224, 1984
Appell RA, Schieid DE, McGuire EJ. Thioridazine-induced priapism. British Journal of Urology 49: 160, 1977
Aronoff GM. Trazodone associated with priapism. Lancet 1: 856, 1984
Benelli R, Fiorini A, Degli Albizi S, Raco P. Priapismo: considerazioni eziopatogenetiche, cliniche e terapeutiche. Minerva Chirurgica 33: 829–837, 1978
Bennett AH, Pilon RN. Non-incisional therapy for priapism. Journal of Urology 125: 208–209, 1981
Benson GS, McConnell JA, Lipshultz LI. Neuromorphology and neuropharmacology of the human penis. Journal of Clinical Investigation 65: 506–513, 1980
Benson GS, McConnell JA, Schmidt WA. Penile posters: functional structures or atherosclerotic changes? Journal of Urology 125: 800–803, 1981
Bergmann JF, Fava P, Bitker MO, Chatelain C, Caulin C, et al. Priapisme au cours d’un traitement par héparinate de calcium. Therapie 42: 250–251, 1987
Bertram RA, Webster GD, Carson CC. Priapism: etiology, treatment and results in series of 35 presentations. Urology 26: 229–232, 1985
Bhalla AK, Hoffbrand BI, Phatak PS, Reuben SR. Prazosin and priapism. British Medical Journal 2: 1039, 1979
Bondil P. Priapism iatrogène par injection intracaverneuse de drogues vasoactives dans le traitement de l’impuissance. Presse Médicale 15: 665, 1986
Boraman MJ, Franz RC, Jacobs DJ, Du Plessis DJ. Thromboxane B2 production during erection. Andrologia 18: 220–223, 1986
Bourgeois M. Priapismes sous neuroleptiques (trois cas). Nouvelle Presse Médicale 1: 1161, 1972
Brindley GS. Cavernosal alpha-blockade and human penile erection. Journal of Physiology 342: 24P, 1983a
Brindley GS. New treatment for priapism. Lancet 1: 220–221, 1984
Brindley GS. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. British Journal of Psychiatry 143: 332–337, 1983b
Burke BJ, Scott GL, Smith PJB, Wakerley GR. Heparin-associated priapism. Postgraduate Medical Journal 59: 332–333, 1983
Burke JR, Hirst G. Priapism and prazosin. Medical Journal of Australia 1: 382, 1980
Carati CJ, Creed KE, Keogh EJ. Autonomic control of penile erection in the dog. Journal of Physiology 384: 525–538, 1987
Carson CC, Mino RD. Priapism associated with trazodone therapy. Journal of Urology 139: 369–370, 1988
Chin JL, Sharpe JR. Priapism and anesthesia: new considerations. Journal of Urology 130: 371, 1983
Clark SK, Tremann JA, Sennewald FR, Donaldson JA. Priapism: an unusual complication of heparin therapy for sudden deafness. American Journal of Otolaryngology 2: 69–72, 1981
Conti G. L’érection du penis humain et ses bases morphologico-vasculaires. Acta Anatomica 14: 217–261, 1952
Dalery F, Follea G, Rochette M, Bertin-Maghit M, Gelet A, et al. Perfusions locales fibrinolytiques dans le traitement du priapisme. Cahiers d’Anesthesiologie 34: 163–168, 1986
Darwish ME, Atassi B, Clark SS. Priapism: evaluation of treatment regimens. Journal of Urology 112: 92–94, 1974
Dawson-Butterworth K. Idiopathic priapism associated with schizophrenia. British Journal of Clinical Practice 23: 125–126, 1969
Dawson-Butterworth K. Priapism and phenothiazines. British Medical Journal 2: 118, 1970
De Leo D, Magni G. Sexual side effects of antidepressant drugs. Psychosomatics 24: 1076–1082, 1983
Dorman BW, Schmidt JD. Association of priapism in phenothiazine therapy. Journal of Urology 116: 51–53, 1976
Duggan ML, Morgan C. Heparin: a cause of priapism? Southern Medical Journal 63: 1131–1134, 1970
Eadie DG, Brock TP. Corpus saphenous by-pass in the treatment of priapism. British Journal of Surgery 57: 172–174, 1970
Editorial. Priapism with trazodone. Medical Letter 26: 35, 1984
Ekström B, Olsson AM. Priapism in patients treated with total parenteral nutrition. British Journal of Urology 59: 170–171, 1987
Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Archives of Internal Medicine 140: 1434–1437, 1980
Enderli JB, Studer UE, Terrier F. Un cas de pseudopriapisme: hématome péricaverneux du pénis. Journal d’Urologie 90: 139–140, 1984
Endres W, Shin YS, Rieth M, Block T, Schmiedt E, et al. Priapism in Fabry’s disease during testosterone treatment. Klinische Wochenschrift 65: 925, 1987
Ercole CJJ, Pontes JE, Pierce JM Jr. Changing surgical concepts in the treatment of priapism. Journal of Urology 125: 210–211, 1981
Eriksson A, Berlin T, Collste L, Von Garrelts B. Priapism: surgical or medical treatment? Scandinavian Journal of Urology and Nephrology 13: 1–3, 1979
Farrer JF, Goodwin WE. Treatment of priapism: comparison of methods in fifteen cases. Journal of Urology 86: 768–775, 1961
Fishbain LA. Priapism resulting from fluphenazine hydrochloride treatment reversed by diphenhydramine. Annals of Emergency Medicine 14: 600–602, 1985
Forsberg L, Mattiasson A, Olsson AM. Priapism: conservative treatment versus surgical procedures. Journal of Urology 53: 374–377, 1981
Fortuño RF, Carrillo R. Gangrene of the penis following caver-nospongiosum shunt in a case of priapism. Journal of Urology 108: 752, 1972
Fovaeus M, Andersson KE, Hedlund H. Effect of some calcium channel blockers on isolated human penile erectile tissues. Journal of Urology 138: 1267–1272, 1987
Funderburk SJ, Philippart M, Dale G, Cederbaun SD, Vyden JK. Priapism after phenoxybenzamine in a patient with Fabry’s disease. New England Journal of Medicine 290: 630, 1974
Gale AS. Ketamine prevention of penile turgescence. Journal of American Medical Association 219: 1629, 1972
Gartrell N. Increased libido in women receiving trazodone. American Journal of Psychiatry 143: 781–782, 1986
Glass RM. Ejaculatory impairment from both phenelzine and imipramine, with tinnitus from phenelzine. Journal of Clinical Psychopharmacology 1: 152–154, 1981
Goldstein AMB, Buckley PA, Meehan JP, Zakhary R, Rogers FA. New observations on microarchitecture of corpora cavernosa in man and possible relationship to mechanism of erection. Urology 20: 259–266, 1982
Gómez EA. Neuroleptic-induced priapism. Texas Medicine 81: 47–48, 1985
Gottlieb JI, Lustberg T. Phenothiazine-induced priapism: a case report. American Journal of Psychiatry 134: 1445–1446, 1977
Goulding FJ. Priapism caused by glucose phosphate isomerase deficiency. Journal of Urology 116: 819–820, 1976
Grace DA, Winter CC. Priapism: an appraisal of management of twenty-three patients. Journal of Urology 99: 301–310, 1968
Graham WP. Nipple priapism. Journal of the American Medical Association 258: 3117, 1987
Grant JA, Scrutton MC. Interaction of selective a-adrenoceptor agonist and antagonists with human and rabbit blood platelets. British Journal of Pharmacology 71: 121–134, 1980
Greenberg WM, Lee KK. Priapism treated with benztropine. American Journal of Psychiatry 144: 384–385, 1987
Griffith SR, Zil JS. Priapism in a patient receiving antipsychotic therapy. Psychosomatics 25: 629–631, 1984
Gu J, Polak JM, Lazarides M, Morgan R, Pryor JP, et al. Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent men. Lancet 2: 315–318, 1984
Halsted DS, Weisel JW, Noble MJ, Mebust WK. Papaverine-induced priapism: 2 case reports. Journal of Urology 136: 109–110, 1986
Hamm B, Friedrich B, Kelami A. Ultrasound imaging of the corpora cavernosa after priapism. European Urology 11: 210–211, 1985
Harrison WH, Rabkin JG, Ehrhardt AA, Stewart JB, McGrath PJ, et al. Effects of antidepressant medication on sexual function: a controlled study. Journal of Clinical Psychopharmacology 6: 144–149, 1986
Harrow BR. Simple technique for treating priapism. Journal of Urology 101: 71–73, 1969
Hasen HB, Raines RL. Priapism associated with sickle cell disease. Journal of Urology 88: 71–76, 1962
Hauri D, Spycher M, Brühlmann W. Erection and priapism: a new physiopathological concept. Urologia Internationalis 38: 138–145, 1983
Hayes PE, Kristoff CA. Adverse reactions to five new antidepressants. Clinical Pharmacology 5: 471–480, 1986
Hillis RS, Weems WL. Priapism: an unusual presentation. Journal of Urology 116: 124–125, 1976
Hollister LE. Tricyclic antidepressants (second of two parts). New England Journal of Medicine 299: 1168–1172, 1978
Jackson N, Franklin IM, Hugues MA. Recurrent priapism following splenectomy for thalassaemia intermedia. British Journal of Surgery 73: 678, 1986
Johnson GR, Corriente JN. Partial priapism. Journal of Urology 124: 147–148, 1980
Jolidon C, Cordier M, Lanson Y. Le priapisme à travers les siècles. Journal d’Urologie 91: 225–226, 1985
Kaisary AV, Smith PJB. Prazosin, priapism and management. British Journal of Urology 58: 227–228, 1986
Kandel GL, Bender LI, Grove JS. Pulmonary embolism: a complication of corpus-saphenous shunt for priapism. Journal of Urology 99: 196, 1968
Khoriaty N, Schick E. Penile gangrene: an unusual complication of priapism. Urology 16: 280–283, 1980
Klein EA, Montague DK, Steiger E. Priapism associated with the use of intravenous fat emulsion: case reports and postulated pathogenesis. Journal of Urology 133: 857–859, 1985
Klein LA, Hall RL, Smith RB. Surgical treatment of priapism: with a note on heparin-induced priapism. Journal of Urology 108: 104–106, 1972
Kogeorgos J, De Alwis C. Priapism and psychotropic medication. British Journal of Psychiatry 149: 241–243, 1986
Krane RJ, Siroky MB. Neurophysiology of erection. Urologic Clinics of North America 8: 91–102, 1981
Lansky MR, Selzer J. Priapism associated with trazodone therapy: a case report. Journal of Clinical Psychiatry 45: 232–233, 1984
Larocque MA, Cosgrove MD. Priapism: a review of 46 cases. Journal of Urology 112: 776, 1974
Law MR, Copland RFP, Armitstead JG, Gabriel R. Labetalol and priapism. British Medical Journal 1280: 115, 1980
Lawrence JM, Stewart TD, Frankel FH. Alpha blockade and priapism. American Journal of Psychiatry 141: 825, 1984
Lazarus A. Priapism and psychotropic drug therapy. Journal of Clinical Psychopharmacology 6: 60–61, 1986
Leal J, Walker D, Egan EA. Idiopathic priapism in the newborn. Journal of Urology 120: 376, 1978
Lindoro J, Castro JC, Cruz F, Marques R. Treatment of priapism. Lancet 2: 1348, 1984
Lladó J, Peterson LLJ, Fair WR. Priapism of the proximal penis. Journal of Urology 123: 779, 1980
Lozano GBL, Castaneda PF. Priapism of the clitoris. British Journal of Urology 53: 390, 1981
Lue TF, Hellstrom WJG, Mcaninch JW, Tanagho EA. Priapism: a defined approach to diagnosis and treatment. Journal of Urology 136: 104–108, 1986
Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. Journal of Urology 137: 829–836, 1987
Macaluso JN, Sullivan JW. Priapism: review of 34 cases. Urology 26: 233–236, 1985
Martelet M, Guy H, Janin-Manificat L, Striffling V, Bonhomme J, et al. Le priapism leucémique: physiopathologie et approche thérapeutique. Seminaires des Hôpitaux de Paris 58: 2511–2516, 1982
Materson BJ. Sexual dysfunction during antihypertensive treatment. Progress in Pharmacology 6(1): 117–124, 1985
Meiraz D, Fishelovitch J. Priapism and largactil medication. Israel Journal of Medical Sciences 5: 1254–1255, 1969
Mitchell JE, Popkin MK. Antipsychotic drug therapy and sexual dysfunction in men. American Journal of Psychiatry 139: 633–637, 1982
Mizutani M, Nakano H, Sagami K, Nihira H. Treatment of post-traumatic priapism by intracavernous injection of alpha-stimulant. Urologia Internationalis 41: 312–314, 1986
Moloney PJ, Elliot GB, Johnson HW. Experiences with priapism. Journal of Urology 114: 72–76, 1975
Montalbán J, Lozano P, Lu L, Gonzalez A. Hemoglobinuria paroxistica nocturna y priapismo. Medicina Clinica 87: 394, 1986
Mustard JF, Murphy EA, Downie HG, Rowsell HC. Heparin and thrombus formation: early suppression and late enhancement. British Journal of Haematology 9: 549–551, 1963
Nagler HM, White R, Roberts M. Familial idiopathic priapism: a case report. Journal of Urology 131: 542–543, 1984
Nellans RE, Ellis LR, Kramer-Levien D. Pharmacological erection: diagnosis and treatment applications in 69 patients. Journal of Urology 138: 52–54, 1987
Nelson JH, Winter CC. Priapism: evolution of management in 48 patients in a 22-year series. Journal of Urology 117: 455–458, 1977
Newman HF, Tschertkoff V. Penile vascular cushions and erection. Investigative Urology 18: 43, 1980
Orvis BR, Lue TF. New therapy for impotence. Urologic Clinics of North America 14: 569–584, 1987
Osborne MP. Penile Parkinsonism. Postgraduate Medical Journal 50: 523–524, 1974
Ottesen B, Wagner G, Virag R, Fahrenkrug J. Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter. British Medical Journal 288: 9–11, 1984
Padma-Nathan H, Goldstein I, Krane RJ. Treatment of prolonged priapistic erection following intracavernosal papaverine therapy. Seminars in Urology 4: 236–238, 1986
Parrillo SJ, Manfrey S. Idiopathic priapism treated with inhalation of amyl nitrite. Annals of Emergency Medicine 12: 226–227, 1983
Patt N. More on trazodone and priapism. American Journal of Psychiatry 142: 783–784, 1985
Pillet J, Chevalier JM, Enor B, Moreau P, Soret JY, et al. Priapisme chez malade traités par héparine. Presse Médicale 13: 1580, 1984
Pohl J, Pott B, Kleinhans G. Priapism: a three-phase concept of management according to aetiology and prognosis. British Journal of Urology 58: 113–118, 1986
Port FK, Fiegel P, Hecking E, Kohler H, Distler A. Priapism during regular haemodialysis. Lancet 2: 1287–1288, 1974
Prasad SB. Priapism. Journal of the Indian Medical Association 81: 20, 1983
Pryor JP. Priapism. Practitioner 226: 1873–1879, 1982
Pryor JP, Hehir M. The management of priapism. British Journal of Urology 54: 751–754, 1982
Puppo P, Belgrano E, Quattrini S, Fabbro V, Repetto V, et al. Treatment of priapism by transcatheter embolization of internal pudendal arteries. Urologic Radiology 5: 261–265, 1983
Rapp MS. Two cases of ejaculatory impairment related to phenelzine. American Journal of Psychiatry 136: 1200–1201, 1979
Raskin DE. Trazodone and priapism. Correspondence. American Journal of Psychiatry 142: 142–143, 1985
Ravindran RS, Dryden GE, Somervile GM. Treatment of priapism with ketamine and physostigmine. Anesthesia and Analgesia 61: 705–707, 1982
Rayner HC, May S, Walls J. Penile erection due to nifedipine. British Medical Journal 296: 137, 1988
Rheinschild GW, Olsen BS, Lippe S, Briton J. An atypical case of priapism with unusual sequelae. Journal of Urology 107: 423–424, 1972
Roa Rico M, Roa Luzuriaga M. Los priapismos parciales: priapismo proximal; aportanción de un caso. Archivos Espanoles de Urologia 34: 297–300, 1981
Robbins DN, Crawford ED, Lackner LH. Priapism secondary to prazosin overdose. Journal of Urology 130: 975, 1983
Rubin SO. Priapism as a probable sequel to medication. Scandinavian Journal of Urology and Nephrology 2: 81–85, 1968
Russell JM, MacGregor RJ, Watson I. Prazosin and priapism. Medical Journal of Australia 143: 321, 1985
Saba V, Muzzonigro G, Mingolla F, Alo F. Attuali concetti patogenetici e terapeutici del priapismo. Minerva Medica 71: 231–233, 1980
Sacks M, Miller F, Gunn J, Paul E, Seilen A. Unusual erectile activity as a side effect of trazodone. Hospital and Community Psychiatry 36: 298, 1985
Sagalowsky AI. Priapism. Urologic Clinics of North America 9: 255–257, 1982
Sale D, Cameron JS. Priapism during regular dialysis. Lancet 2: 1567–1568, 1974
Scher M, Krieger J, Juergens S. Trazodone in priapism. American Journal of Psychiatry 140: 1362–1363, 1983
Seeler RA. Priapism in children with sickle cell anemia; successful management with liberal red cell transfusion. Clinical Pediatrics 10: 418–419, 1971
Segasothy M. Prazosin and priapism. Medical Journal of Malaysia 37: 384, 1982
Serjeant GR, De Ceulaer K, Maude GH. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 2: 1274–1276, 1985
Sharrock AG. Reversal of drug induced priapism in a gelding by medication. Australian Veterinary Journal 586: 39–40, 1982
Shirley RL. Nipple priapism. Journal of the American Medical Association 257: 3420, 1987
Sözer IT. The treatment of priapism by a new antihypertensive drug: sodium nitroprusside and penile aspiration. Journal of Urology 99: 311–313, 1968
Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. Journal of Urology 135: 142–147, 1986
Stanners A, Colin-Jones D. Metaraminol for priapism. Lancet 2: 978, 1984
Stiles AD. Priapism following a black widow spider bite. Clinical Pediatrics 21: 174–175, 1982
Taha SA, Sharayah A, Salem A, Knox-Macaulay H. Homozygous sickle cell disease and priapism in the Eastern Province of Saudi Arabia. Acta Haematologica 77: 60–61, 1987
Taylor WN. Priapism of the corpus spongiosum and glans penis. Journal of Urology 123: 961, 1980
Trulock TS, Wheatley TK, Walton KN. Secondary tumors of the penis. Urology 17: 563, 1981
Velek M, Stanford DK, Marco L. Priapism associated with concurrent use of thioridazine and metoclopramide. American Journal of Psychiatry 144: 27–828, 1987
Virag R, Ottesen B, Fahrenkrug J, Levy C, Wagnar G. Vasoactive intestinal polypeptide release during penile erection in man. Lancet 2: 1166, 1982
Wagner G, Willis EA, Bro-Rasmussen F, Nielsen MH. New theory on the mechanism of erection involving hitherto undescribed vessels. Lancet 1: 416–418, 1982
Warner MD, Peabody CA, Whiteford HA, Hollister LE. Trazo-done and priapism. Journal of Clinical Psychiatry 48: 244–245, 1987
Wasmer JM, Carrion HM, Mekras G, Politano VA. Evaluation and treatment of priapism. Journal of Urology 125: 204–207, 1981
Weiss HD. The physiology of human penile erection. Annals of Internal Medicine 76: 793, 1972
Welford C, Spies SM, Green G. Priapism in primary thrombo-cythemia. Archives of Internal Medicine 141: 807–808, 1981
Welti RS, Brodsky JB. Treatment of intraoperative penile tumescence. Journal of Urology 124: 925–926, 1980
Wickham JEA. Aortic rupture presenting with hematuria and priapism. British Journal of Urology 1: 89, 1964
Willis E, Ottesen B, Wagner G, Sundler F, Fahrenkrug J. Vaso-active intestinal polypeptide (VIP) as a putative neurotrans-mitter in penile erection. Life Sciences 33: 383–391, 1983
Winter CC. Cure of priapism: new procedure for creating fistula between glans penis and corpora cavernosa. Urology 8: 389, 1976
Winter CC. Priapism. Urologic Survey 28: 163–166, 1978
Winter CC. Priapism. Journal of Urology 125: 212, 1981
Witters S, Cornelissen M, Vereecken RL. Malignant priapism. European Urology 11: 431–432, 1985
Yeragani VK, Aleem A, Pohl R, Gershon S. Neuropharmacological basis of priapism. Clinical Neuropharmacology 10: 93–95, 1987
Yeragani VK, Gershon S. Priapism related to phenelzine therapy. New England Journal of Medicine 317: 117–118, 1987
Ylitalo P, Pasternak A. Priapism: side effect of prazosin in patients with renal failure. Acta Medica Scandinavica 213: 319–320, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baños, J.E., Bosch, F. & Farré, M. Drug-Induced Priapism Its Aetiology, Incidence and Treatment. Med Toxicol Adverse Drug Exp 4, 46–58 (1989). https://doi.org/10.1007/BF03259902
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259902